BIOCUREX INC
CIK 0001092562
Revenue (TTM)
$30.81K
Q3 Nov 2012
Net Income (TTM)
−$2.37M
+20.9% YoY
Q3 Nov 2012
EPS Diluted (TTM)
—
Q3 Nov 2012
Gross Margin
—
Q3 Nov 2012
Operating Margin
-6,514.9%
Q3 Nov 2012
Net Margin
-7,687.1%
Q3 Nov 2012
Free Cash Flow (TTM)
—
Q3 Nov 2012
Cash
—
Q3 Nov 2012
Total Debt
$480K
Q3 Nov 2012
Shares Outstanding
308.66M sh
Q3 Nov 2012
Revenue & Net Income
Margins
Cash Flow
Revenue Growth (YoY)
No data available for this metric.